Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits

The Biden administration on Tuesday unveiled the first 10 drugs subject to Medicare price negotiations, promising billions of dollars in savings for the federal government and the nine million Medicare beneficiaries taking at least one of the popular medications.
Medicare has been banned from directly negotiating lower drug prices since 2003, but the Inflation Reduction Act opened the door to some haggling. "This is a major step toward reducing drug spending," Stacie Dusetzina, a drug pricing expert at Vanderbilt University School of Medicine, told The Wall Street Journal.
The companies that make the 10 drugs have until Oct. 1 to inform the government if they will negotiate. If not, they face steep excise taxes and could be barred from Medicare and Medicaid. The drug negotiations would begin in 2024, and the price cuts would take effect in 2026. Medicare plans to add another 15 drugs to negotiate in 2027, 15 more in 2028, then up to 20 drugs a year after that.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The government's savings will support an IRA program to cap out-of-pocket drug costs for Medicare beneficiaries at $2,000 a year, starting in 2025. A provision that capped insulin costs at $35 a month took effect earlier this year.
Six drugmakers, plus the U.S. Chamber of Commerce and the industry lobbying group PhARMA, have filed suit to block the federal drug negotiations, arguing they are unconstitutional. "Piggybacking on the pharmaceutical industry's strategy, Republicans are working to persuade Americans that the Biden plan will stifle innovation and lead to price controls," Politico reported, citing Republican strategists.
Recent Kaiser Family Foundation polling found that 89% of Democrats and 77% of Republicans favor the part of the IRA that allows Medicare to negotiate drug prices. If Republicans "want to run their campaigns based on keeping the profits of the drug companies high, welcome," Sen. Amy Klobuchar (D-Minn.) told Politico.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Snow White: Disney's 'earnest effort to meet an impossible brief'
Talking Point Live-action remake of Disney classic is not the disaster it could have been – but where's the personality?
By The Week UK Published
-
Don McCullin picks his favourite books
The Week Recommends The photojournalist shares works by Daniel Defoe, Lesley Blanch and Roland Philipps
By The Week UK Published
-
The week's best photos
In Pictures A fiery cocktail, deathly fashion, and more
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published